true
2001-02-21
2024-03-27
200
ZN281_HUMAN
ZBP-99 defines a conserved family of transcription factors and regulates ornithine decarboxylase gene expression.
Law D.J.
Du M.
Law G.L.
Merchant J.L.
doi:10.1006/bbrc.1999.1180
1999
Biochem. Biophys. Res. Commun.
262
113-120
NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)
FUNCTION
SUBCELLULAR LOCATION
Identification of human GC-box-binding zinc finger protein, a new Krueppel-like zinc finger protein, by the yeast one-hybrid screening with a GC-rich target sequence.
Lisowsky T.
Loguercio Polosa P.
Sagliano A.
Roberti M.
Gadaleta M.N.
Cantatore P.
doi:10.1016/s0014-5793(99)00754-1
1999
FEBS Lett.
453
369-374
NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)
Liver
Complete sequencing and characterization of 21,243 full-length human cDNAs.
Ota T.
Suzuki Y.
Nishikawa T.
Otsuki T.
Sugiyama T.
Irie R.
Wakamatsu A.
Hayashi K.
Sato H.
Nagai K.
Kimura K.
Makita H.
Sekine M.
Obayashi M.
Nishi T.
Shibahara T.
Tanaka T.
Ishii S.
Yamamoto J.
Saito K.
Kawai Y.
Isono Y.
Nakamura Y.
Nagahari K.
Murakami K.
Yasuda T.
Iwayanagi T.
Wagatsuma M.
Shiratori A.
Sudo H.
Hosoiri T.
Kaku Y.
Kodaira H.
Kondo H.
Sugawara M.
Takahashi M.
Kanda K.
Yokoi T.
Furuya T.
Kikkawa E.
Omura Y.
Abe K.
Kamihara K.
Katsuta N.
Sato K.
Tanikawa M.
Yamazaki M.
Ninomiya K.
Ishibashi T.
Yamashita H.
Murakawa K.
Fujimori K.
Tanai H.
Kimata M.
Watanabe M.
Hiraoka S.
Chiba Y.
Ishida S.
Ono Y.
Takiguchi S.
Watanabe S.
Yosida M.
Hotuta T.
Kusano J.
Kanehori K.
Takahashi-Fujii A.
Hara H.
Tanase T.-O.
Nomura Y.
Togiya S.
Komai F.
Hara R.
Takeuchi K.
Arita M.
Imose N.
Musashino K.
Yuuki H.
Oshima A.
Sasaki N.
Aotsuka S.
Yoshikawa Y.
Matsunawa H.
Ichihara T.
Shiohata N.
Sano S.
Moriya S.
Momiyama H.
Satoh N.
Takami S.
Terashima Y.
Suzuki O.
Nakagawa S.
Senoh A.
Mizoguchi H.
Goto Y.
Shimizu F.
Wakebe H.
Hishigaki H.
Watanabe T.
Sugiyama A.
Takemoto M.
Kawakami B.
Yamazaki M.'
Watanabe K.
Kumagai A.
Itakura S.
Fukuzumi Y.
Fujimori Y.
Komiyama M.
Tashiro H.
Tanigami A.
Fujiwara T.
Ono T.
Yamada K.
Fujii Y.
Ozaki K.
Hirao M.
Ohmori Y.
Kawabata A.
Hikiji T.
Kobatake N.
Inagaki H.
Ikema Y.
Okamoto S.
Okitani R.
Kawakami T.
Noguchi S.
Itoh T.
Shigeta K.
Senba T.
Matsumura K.
Nakajima Y.
Mizuno T.
Morinaga M.
Sasaki M.
Togashi T.
Oyama M.
Hata H.
Watanabe M.'
Komatsu T.
Mizushima-Sugano J.
Satoh T.
Shirai Y.
Takahashi Y.
Nakagawa K.
Okumura K.
Nagase T.
Nomura N.
Kikuchi H.
Masuho Y.
Yamashita R.
Nakai K.
Yada T.
Nakamura Y.'
Ohara O.
Isogai T.
Sugano S.
doi:10.1038/ng1285
2004
Nat. Genet.
36
40-45
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)
The DNA sequence and biological annotation of human chromosome 1.
Gregory S.G.
Barlow K.F.
McLay K.E.
Kaul R.
Swarbreck D.
Dunham A.
Scott C.E.
Howe K.L.
Woodfine K.
Spencer C.C.A.
Jones M.C.
Gillson C.
Searle S.
Zhou Y.
Kokocinski F.
McDonald L.
Evans R.
Phillips K.
Atkinson A.
Cooper R.
Jones C.
Hall R.E.
Andrews T.D.
Lloyd C.
Ainscough R.
Almeida J.P.
Ambrose K.D.
Anderson F.
Andrew R.W.
Ashwell R.I.S.
Aubin K.
Babbage A.K.
Bagguley C.L.
Bailey J.
Beasley H.
Bethel G.
Bird C.P.
Bray-Allen S.
Brown J.Y.
Brown A.J.
Buckley D.
Burton J.
Bye J.
Carder C.
Chapman J.C.
Clark S.Y.
Clarke G.
Clee C.
Cobley V.
Collier R.E.
Corby N.
Coville G.J.
Davies J.
Deadman R.
Dunn M.
Earthrowl M.
Ellington A.G.
Errington H.
Frankish A.
Frankland J.
French L.
Garner P.
Garnett J.
Gay L.
Ghori M.R.J.
Gibson R.
Gilby L.M.
Gillett W.
Glithero R.J.
Grafham D.V.
Griffiths C.
Griffiths-Jones S.
Grocock R.
Hammond S.
Harrison E.S.I.
Hart E.
Haugen E.
Heath P.D.
Holmes S.
Holt K.
Howden P.J.
Hunt A.R.
Hunt S.E.
Hunter G.
Isherwood J.
James R.
Johnson C.
Johnson D.
Joy A.
Kay M.
Kershaw J.K.
Kibukawa M.
Kimberley A.M.
King A.
Knights A.J.
Lad H.
Laird G.
Lawlor S.
Leongamornlert D.A.
Lloyd D.M.
Loveland J.
Lovell J.
Lush M.J.
Lyne R.
Martin S.
Mashreghi-Mohammadi M.
Matthews L.
Matthews N.S.W.
McLaren S.
Milne S.
Mistry S.
Moore M.J.F.
Nickerson T.
O'Dell C.N.
Oliver K.
Palmeiri A.
Palmer S.A.
Parker A.
Patel D.
Pearce A.V.
Peck A.I.
Pelan S.
Phelps K.
Phillimore B.J.
Plumb R.
Rajan J.
Raymond C.
Rouse G.
Saenphimmachak C.
Sehra H.K.
Sheridan E.
Shownkeen R.
Sims S.
Skuce C.D.
Smith M.
Steward C.
Subramanian S.
Sycamore N.
Tracey A.
Tromans A.
Van Helmond Z.
Wall M.
Wallis J.M.
White S.
Whitehead S.L.
Wilkinson J.E.
Willey D.L.
Williams H.
Wilming L.
Wray P.W.
Wu Z.
Coulson A.
Vaudin M.
Sulston J.E.
Durbin R.M.
Hubbard T.
Wooster R.
Dunham I.
Carter N.P.
McVean G.
Ross M.T.
Harrow J.
Olson M.V.
Beck S.
Rogers J.
Bentley D.R.
doi:10.1038/nature04727
2006
Nature
441
315-321
NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]
The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).
The MGC Project Team
doi:10.1101/gr.2596504
2004
Genome Res.
14
2121-2127
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)
Placenta
Skin
ZBP-89 represses vimentin gene transcription by interacting with the transcriptional activator, Sp1.
Zhang X.
Diab I.H.
Zehner Z.E.
doi:10.1093/nar/gkg380
2003
Nucleic Acids Res.
31
2900-2914
FUNCTION
ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage.
Matsuoka S.
Ballif B.A.
Smogorzewska A.
McDonald E.R. III
Hurov K.E.
Luo J.
Bakalarski C.E.
Zhao Z.
Solimini N.
Lerenthal Y.
Shiloh Y.
Gygi S.P.
Elledge S.J.
doi:10.1126/science.1140321
2007
Science
316
1160-1166
PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-395; SER-785 AND SER-807
IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]
Embryonic kidney
Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle.
Daub H.
Olsen J.V.
Bairlein M.
Gnad F.
Oppermann F.S.
Korner R.
Greff Z.
Keri G.
Stemmann O.
Mann M.
doi:10.1016/j.molcel.2008.07.007
2008
Mol. Cell
31
438-448
IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]
Cervix carcinoma
A quantitative atlas of mitotic phosphorylation.
Dephoure N.
Zhou C.
Villen J.
Beausoleil S.A.
Bakalarski C.E.
Elledge S.J.
Gygi S.P.
doi:10.1073/pnas.0805139105
2008
Proc. Natl. Acad. Sci. U.S.A.
105
10762-10767
PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-484
IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]
Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach.
Gauci S.
Helbig A.O.
Slijper M.
Krijgsveld J.
Heck A.J.
Mohammed S.
doi:10.1021/ac9004309
2009
Anal. Chem.
81
4493-4501
IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]
Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.
Olsen J.V.
Vermeulen M.
Santamaria A.
Kumar C.
Miller M.L.
Jensen L.J.
Gnad F.
Cox J.
Jensen T.S.
Nigg E.A.
Brunak S.
Mann M.
doi:10.1126/scisignal.2000475
2010
Sci. Signal.
3
RA3
IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]
Initial characterization of the human central proteome.
Burkard T.R.
Planyavsky M.
Kaupe I.
Breitwieser F.P.
Buerckstuemmer T.
Bennett K.L.
Superti-Furga G.
Colinge J.
doi:10.1186/1752-0509-5-17
2011
BMC Syst. Biol.
5
17
IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]
System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation.
Rigbolt K.T.
Prokhorova T.A.
Akimov V.
Henningsen J.
Johansen P.T.
Kratchmarova I.
Kassem M.
Mann M.
Olsen J.V.
Blagoev B.
doi:10.1126/scisignal.2001570
2011
Sci. Signal.
4
RS3
IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]
N-terminal acetylome analyses and functional insights of the N-terminal acetyltransferase NatB.
Van Damme P.
Lasa M.
Polevoda B.
Gazquez C.
Elosegui-Artola A.
Kim D.S.
De Juan-Pardo E.
Demeyer K.
Hole K.
Larrea E.
Timmerman E.
Prieto J.
Arnesen T.
Sherman F.
Gevaert K.
Aldabe R.
doi:10.1073/pnas.1210303109
2012
Proc. Natl. Acad. Sci. U.S.A.
109
12449-12454
IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]
Toward a comprehensive characterization of a human cancer cell phosphoproteome.
Zhou H.
Di Palma S.
Preisinger C.
Peng M.
Polat A.N.
Heck A.J.
Mohammed S.
doi:10.1021/pr300630k
2013
J. Proteome Res.
12
260-271
PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-651
IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]
Erythroleukemia
An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.
Bian Y.
Song C.
Cheng K.
Dong M.
Wang F.
Huang J.
Sun D.
Wang L.
Ye M.
Zou H.
doi:10.1016/j.jprot.2013.11.014
2014
J. Proteomics
96
253-262
PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-651 AND THR-888
IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]
Uncovering global SUMOylation signaling networks in a site-specific manner.
Hendriks I.A.
D'Souza R.C.
Yang B.
Verlaan-de Vries M.
Mann M.
Vertegaal A.C.
doi:10.1038/nsmb.2890
2014
Nat. Struct. Mol. Biol.
21
927-936
SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-128; LYS-213; LYS-232; LYS-409; LYS-416; LYS-622; LYS-787 AND LYS-795
IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]
SUMO-2 orchestrates chromatin modifiers in response to DNA damage.
Hendriks I.A.
Treffers L.W.
Verlaan-de Vries M.
Olsen J.V.
Vertegaal A.C.
doi:10.1016/j.celrep.2015.02.033
2015
Cell Rep.
10
1778-1791
SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-128; LYS-225; LYS-498 AND LYS-795
IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]
System-wide analysis of SUMOylation dynamics in response to replication stress reveals novel small ubiquitin-like modified target proteins and acceptor lysines relevant for genome stability.
Xiao Z.
Chang J.G.
Hendriks I.A.
Sigurdsson J.O.
Olsen J.V.
Vertegaal A.C.
doi:10.1074/mcp.o114.044792
2015
Mol. Cell. Proteomics
14
1419-1434
SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-128
IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]
Site-specific mapping of the human SUMO proteome reveals co-modification with phosphorylation.
Hendriks I.A.
Lyon D.
Young C.
Jensen L.J.
Vertegaal A.C.
Nielsen M.L.
doi:10.1038/nsmb.3366
2017
Nat. Struct. Mol. Biol.
24
325-336
SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-2; LYS-101; LYS-128; LYS-213; LYS-219; LYS-225; LYS-232; LYS-242; LYS-259; LYS-301; LYS-325; LYS-373; LYS-409; LYS-416; LYS-460; LYS-477; LYS-493; LYS-498; LYS-539; LYS-599; LYS-617; LYS-622; LYS-661; LYS-670; LYS-787; LYS-792; LYS-795; LYS-818 AND LYS-840
SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-65 (ISOFORM 2)
IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]
The consensus coding sequences of human breast and colorectal cancers.
Sjoeblom T.
Jones S.
Wood L.D.
Parsons D.W.
Lin J.
Barber T.D.
Mandelker D.
Leary R.J.
Ptak J.
Silliman N.
Szabo S.
Buckhaults P.
Farrell C.
Meeh P.
Markowitz S.D.
Willis J.
Dawson D.
Willson J.K.V.
Gazdar A.F.
Hartigan J.
Wu L.
Liu C.
Parmigiani G.
Park B.H.
Bachman K.E.
Papadopoulos N.
Vogelstein B.
Kinzler K.W.
Velculescu V.E.
doi:10.1126/science.1133427
2006
Science
314
268-274
VARIANT [LARGE SCALE ANALYSIS] THR-527
Different initiation.
166
106
1 O-GlcNAc glycan (1 site)
22 sites, 2 glycans
29 sites, 2 O-linked glycans (29 sites)
229 antibodies from 32 providers
human
ZNF281
Tissue enhanced (bone)
gene
Eukaryota
26 hits in 1174 CRISPR screens
human
Tbio
Protein
Expressed in secondary oocyte and 206 other cell types or tissues
Classic Zinc Finger
Znf_C2H2_sf
Znf_C2H2_type
ZINC FINGER PROTEIN
ZINC FINGER PROTEIN 281-LIKE ISOFORM X1
zf-C2H2
ZnF_C2H2
beta-beta-alpha zinc fingers
ZINC_FINGER_C2H2_1
ZINC_FINGER_C2H2_2
HS
Zinc finger protein 281
GC-box-binding zinc finger protein 1
Transcription factor ZBP-99
Zinc finger DNA-binding protein 99
ZNF281
GZP1
ZBP99
Transcription repressor that plays a role in regulation of embryonic stem cells (ESCs) differentiation. Required for ESCs differentiation and acts by mediating autorepression of NANOG in ESCs: binds to the NANOG promoter and promotes association of NANOG protein to its own promoter and recruits the NuRD complex, which deacetylates histones. Not required for establishement and maintenance of ESCs (By similarity). Represses the transcription of a number of genes including GAST, ODC1 and VIM. Binds to the G-rich box in the enhancer region of these genes.
Belongs to the krueppel C2H2-type zinc-finger protein family.
Extended N-terminus.
Zinc finger protein 281
96915
1
895
C2H2-type 1
261
283
C2H2-type 2
289
311
C2H2-type 3
317
339
C2H2-type 4; atypical
345
367
Disordered
44
Disordered
63
113
Disordered
130
149
Disordered
183
253
Disordered
377
427
Disordered
638
660
Disordered
778
817
Basic and acidic residues
197
232
Polar residues
406
Basic and acidic residues
407
421
Polar residues
644
Phosphoserine
395
Phosphoserine
484
Phosphoserine
651
Phosphoserine
785
Phosphoserine
807
Phosphothreonine
888
Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
2
Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
101
Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
128
Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
213
Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
219
Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
225
Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
242
Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
259
Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
301
Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
325
Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
373
Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
409
Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
416
Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
460
Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
477
Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
493
Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
498
Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
539
Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
599
Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
617
Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
622
Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
661
Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
670
Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
787
Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
792
Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
795
Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
818
Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
840
In isoform 2.
49
84
In a breast cancer sample; somatic mutation.
T
527
L
Y
206
L
482
I
635
Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
65
false
3
false
3
false
3
HTT
OPTN
PMP22
1999-11-01
1
96915
137679baed40c0f17977599079867897
1
MKIGSGFLSGGGGTGSSGGSGSGGGGSGGGGGGGSSGRRAEMEPTFPQGMVMFNHRLPPVTSFTRPAGSAAPPPQCVLSSSTSAAPAAEPPPPPAPDMTFKKEPAASAAAFPSQRTSWGFLQSLVSIKQEKPADPEEQQSHHHHHHHHYGGLFAGAEERSPGLGGGEGGSHGVIQDLSILHQHVQQQPAQHHRDVLLSSSSRTDDHHGTEEPKQDTNVKKAKRPKPESQGIKAKRKPSASSKPSLVGDGEGAILSPSQKPHICDHCSAAFRSSYHLRRHVLIHTGERPFQCSQCSMGFIQKYLLQRHEKIHSREKPFGCDQCSMKFIQKYHMERHKRTHSGEKPYKCDTCQQYFSRTDRLLKHRRTCGEVIVKGATSAEPGSSNHTNMGNLAVLSQGNTSSSRRKTKSKSIAIENKEQKTGKTNESQISNNINMQSYSVEMPTVSSSGGIIGTGIDELQKRVPKLIFKKGSRKNTDKNYLNFVSPLPDIVGQKSLSGKPSGSLGIVSNNSVETIGLLQSTSGKQGQISSNYDDAMQFSKKRRYLPTASSNSAFSINVGHMVSQQSVIQSAGVSVLDNEAPLSLIDSSALNAEIKSCHDKSGIPDEVLQSILDQYSNKSESQKEDPFNIAEPRVDLHTSGEHSELVQEENLSPGTQTPSNDKASMLQEYSKYLQQAFEKSTNASFTLGHGFQFVSLSSPLHNHTLFPEKQIYTTSPLECGFGQSVTSVLPSSLPKPPFGMLFGSQPGLYLSALDATHQQLTPSQELDDLIDSQKNLETSSAFQSSSQKLTSQKEQKNLESSTGFQIPSQELASQIDPQKDIEPRTTYQIENFAQAFGSQFKSGSRVPMTFITNSNGEVDHRVRTSVSDFSGYTNMMSDVSEPCSTRVKTPTSQSYR
2
MKIGSGFLSGGGGTGSSGGSGSGGGGSGGGGGGGSSGRRAEMEPTFPQAPAAEPPPPPAPDMTFKKEPAASAAAFPSQRTSWGFLQSLVSIKQEKPADPEEQQSHHHHHHHHYGGLFAGAEERSPGLGGGEGGSHGVIQDLSILHQHVQQQPAQHHRDVLLSSSSRTDDHHGTEEPKQDTNVKKAKRPKPESQGIKAKRKPSASSKPSLVGDGEGAILSPSQKPHICDHCSAAFRSSYHLRRHVLIHTGERPFQCSQCSMGFIQKYLLQRHEKIHSREKPFGCDQCSMKFIQKYHMERHKRTHSGEKPYKCDTCQQYFSRTDRLLKHRRTCGEVIVKGATSAEPGSSNHTNMGNLAVLSQGNTSSSRRKTKSKSIAIENKEQKTGKTNESQISNNINMQSYSVEMPTVSSSGGIIGTGIDELQKRVPKLIFKKGSRKNTDKNYLNFVSPLPDIVGQKSLSGKPSGSLGIVSNNSVETIGLLQSTSGKQGQISSNYDDAMQFSKKRRYLPTASSNSAFSINVGHMVSQQSVIQSAGVSVLDNEAPLSLIDSSALNAEIKSCHDKSGIPDEVLQSILDQYSNKSESQKEDPFNIAEPRVDLHTSGEHSELVQEENLSPGTQTPSNDKASMLQEYSKYLQQAFEKSTNASFTLGHGFQFVSLSSPLHNHTLFPEKQIYTTSPLECGFGQSVTSVLPSSLPKPPFGMLFGSQPGLYLSALDATHQQLTPSQELDDLIDSQKNLETSSAFQSSSQKLTSQKEQKNLESSTGFQIPSQELASQIDPQKDIEPRTTYQIENFAQAFGSQFKSGSRVPMTFITNSNGEVDHRVRTSVSDFSGYTNMMSDVSEPCSTRVKTPTSQSYR
true
true
true
true
true
true
true
true
true
true
true
true
true
true
true
true
true
true
true
true